Position in PYXS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$169,368
+$35,962 QoQ
Shares Held
116,006
0.0% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 78 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NewEdge Wealth, LLC holds $20,244,273 across 19 Biotechnology names. PYXS ranks #16 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,788 | $4,370,733 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,201 | $3,044,334 | |
| 3 | BHVN |
Biohaven Ltd.
|
246,503 | $2,085,415 | |
| 4 | EXEL |
Exelixis, Inc.
|
42,331 | $1,815,576 | |
| 5 | INVA |
Innoviva, Inc.
|
77,134 | $1,797,222 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
27,887 | $1,124,124 | |
| 7 | NVAX |
Novavax Inc
|
130,000 | $1,058,200 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
21,856 | $711,194 |
All Filings in PYXS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $169,368 | 116,006 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $133,406 | 116,006 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $257,533 | 116,006 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $127,606 | 116,006 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $113,685 | 116,006 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $180,974 | 116,009 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $425,742 | 116,006 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||